The Board of Directors of Albireo (the "Company") sets high standards for the Company's employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company's business. To fulfill its responsibilities and to discharge its duty, the Board of Directors follows the procedures and standards that are set forth in these guidelines. These guidelines are subject to modification from time to time as the Board of Directors deems appropriate in the best interests of the Company or as required by applicable laws and regulations.
Environmental, social, and governance (ESG)
Environmental Sustainability
A healthy planet is key to a better future and our continued hope for families. At Albireo, we prioritize positive contributions for our communities, patients, families, and colleagues through sustainable actions. Our mission is a collective effort with our partners to manage and minimize the environmental footprint we contribute to society. This collaboration with selectively chosen supply manufacturing partners ensures we are working to protect the environment, prevent environmental pollution, comply with environmental, health, safety and security EHSS statutory requirements, and more.
As a responsible member of the global biopharma industry, we continue to look for ways to build sustainability into our company culture to limit the footprint internally and with global customers.
Our new Albireo headquarters is a LEED-EB Gold Certified high-performance building by Beacon that operates all of its properties in a resource-efficient manner. To date, Beacon has obtained LEED certification for over 56 million square feet of property.
In addition, our new hybrid working model as well as office recycling programs also support environmental sustainability. This includes our global offices taking part in single source garbage and recycling receptacles, paper recycling through shredding programs, as well as employees limiting emissions through a hybrid work model where employees are only commuting two days a week.
Social Impact
Albireo is committed to embracing differences, working with purpose and transforming science for the well-being of our patients and their families, our colleagues and partners. As an inclusive and inviting work environment, we embrace different perspectives and celebrate how our different voices inspire us to put strategies and programs in place that keep our patients first and at the center of all we do.
We are proud partners of community-based and global organizations including:
Diversity, Equity & Inclusion (DE&I)
Diversity, equity, and inclusion are essential to society, and especially in Albireo’s efforts to better serve patients and their families. We are committed to work each day, united by a common purpose to create a diverse, equitable and inclusive environment that treats all employees with respect and provides equal opportunities to develop and succeed within the company.
We are an equal opportunity employer. With our open-door policy, we encourage collaboration and transparent communication. We are committed to achieving excellence by focusing on execution and teamwork and belonging. Our belief in an inclusive environment extends beyond those within Albireo, and encompasses the patients, families and communities we serve. We believe in access to treatments for all who need them, knowing everyone should have the opportunity for their lives to transform through accessible solutions.
Additionally, Albireo meets the following requirements including, but not limited to:
- Albireo meets all of the requirements of NASDAQ’s Board Diversity Disclosure, New Rule 5605(f), requiring at least two diverse directors, including: at least one self-identified female director; and. at least one director who self-identifies as an underrepresented minority to be on the Board.
- Albireo is committed to equitable representation which is shown through our enterprise team that provides diverse perspectives to help guide and grow our company.
Inclusive Culture
We are committed to enhance our efforts to ensure a fully inclusive culture for our A-team. These efforts will continue to secure our place as a leading employer of choice, an important advocate within the patient and family communities, and as continued leader in the industry providing hope for families.
Current programs to support our goals include:
- Diverse recruiting initiatives and partnerships
- Cross-cultural awareness initiatives
- Community outreach programs
Albireo is dedicated to fostering a positive and inclusive work environment, continued workplace development opportunities and diversity, equity and inclusion across the pharmaceutical industry.
Access to Medicines, Affordability & Pricing
Our mission is to provide hope for families by delivering innovative and accessible solutions to tranform the lives of patients and their families living with rare cholestatic liver diseases. We succeed in our mission only if our products reach the patients who will benefit from them, so we prioritize patient access in everything we do.
For our first product Bylvay™ (odevixibat), we determined the price based on its value and impact on patients, families and caregivers. As such, we are guided by the following principles:
- Improve patients lives and well-being.
- Work to remove insurance-related barriers that can hinder the patient's ability to undergo treatment.
- Prioritize access by providing individualized and customized financial assistance to eligible patients.
- Continue innovating to discover and develop treatments for cholestatic liver diseases.
In our commitment to ensuring that eligible patients can access ByIvayTM (odevixibat) in a fully compliant manner, we will work within the relevant regulatory processes for each country to meet our ongoing commitment to patients and to support the PFIC community.
- For PFIC patients in the U.S., Albireo has built a customized and company-run patient services program called AlbireoAssist™. To learn more about the program, visit AlbireoAssist.com.
- For PFIC patients outside the U.S., access to Bylvay in certain countries is now available through our Managed Access Program. For PFIC patients in Germany, we also offer Albireo Assist Germany, a patient support program for patients and caregivers of children diagnosed with PFIC to accompany Bylvay and optimize outcomes.
- The Company also provides an Expanded Access Program (EAP) for eligible patients with PFIC in the U.S., England, Wales and Northern Ireland, Germany, Canada and Australia with many more to come in Europe.
Manufacturing Safety and Employee Safety
Employee safety is a critical part of an employer’s responsibility. Albireo is committed to providing our employees with a safe workplace. Reducing incidents is a priority and we are continuously improving our systems to prevent incidents and ensure operations are safe. When incidents occur, it is important to understand the causes, share the learnings and ensure corrective actions are implemented to prevent recurrence.
